散血明目片联合激光治疗糖尿病性生视网膜病变的疗效观察

目的:观察应用散血明目片联合激光治疗糖尿病性视网膜病变的疗效。方法:选择确诊为重度非增生性及增生性的糖尿病性视网膜病变患者81例(141只眼)并随机分组、对照治疗。根据FFA结果行标准全视网膜光凝,有临床意义的黄斑水肿者先行黄斑部格栅样或局灶性光凝,再行全视网膜光凝。药物联合激光组41例(72只眼),光凝后口服散血明目片,连续3月;单纯激光组40例(69只眼)采用单纯光凝治疗。结果:药物联合激光组有效率为91.7%,优于单纯激光组的79.7%(P<0.05)。药物联合激光组视力提高和不变率为90.3%,优于单纯激光组的76.8(%P<0.05)。结论:散血明目片联合激光治疗可有效地治疗糖尿病性视网膜病变。

Clinical Observation on the Treatment of Diabetic Retinopathy With Sanxuemingmu Tablet and Laser

Objective: To observe the effect of Sanxuemingmu tablet and laser on diabetic retinopathy.Methods: Eighty-one patients(141 eyes) were randomly divided into two groups,drugs together with laser group with 41 patients(72 eyes) took Sanxuemingmu tablet orally after laser therapy,taking 3 monthes successivly,pure laser group wih 40 patients(69 eyes) were only treated with laser.Results: The effective rate was 91.7% in drugs together with laser group,79.7% in pure laser group,the difference had statistical significance(P<0.05),so did sight improving and unvaried rate.Conclusion: Sanxuemingmu tablet together with laser can effectively treat diabetic retinopathy.